Medicenna takes on deadly brain cancer in clinical trial July 8, 2021 Auto Bot Clinical Development 0 The immunotherapy firm is conducting a Phase III trial centered on an innovative approach to treating recurrent glioblastoma, an aggressive brain cancer.